Zhang X#, Liang H#, Li Z#, Xue Y#, Wang Y, Zhou Z, Yu J, Bu Z, Chen L, Du Y, Wang X, Wu A, Li G, Su X, Xiao G, Cui M, Wu D, Chen L, Wu X, Zhou Y, Zhang L, Dang C, He Y, Zhang Z, Sun Y, Li Y, Chen H, Bai Y, Qi C, Yu P, Zhu G, Suo J, Jia B, Li L, Huang C, Li F, Ye Y, Xu H, Wang X, Yuan Y, E JY, Ying X, Yao C, Shen L, Ji J; RESOLVE study group. Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): an open-label, superiority and non-inferiority, phase 3 randomised controlled trial.,Lancet Oncol,22(8):1081-1092.

Li Z, Gao X, Peng X, May Chen MJ, Li Z, Wei B, Wen X, Wei B, Dong Y, Bu Z, Wu A, Wu Q, Tang L, Li Z, Liu Y, Zhang L, Jia S, Zhang L, Shan F, Zhang J, Wu X, Ji X, Ji K, Wu X, Shi J, Xing X, Wu J, Lv G, Shen L, Ji X, Liang H, Ji J. Multi-omics characterization of molecular features of gastric cancer correlated with response to neoadjuvant chemotherapy.,Science Advances,26;6(9):eaay4211.

Tang XH, Guo T, Gao XY, Wu XL, Xing XF*, Ji JF*, Li ZY*. Exosome-derived noncoding RNAs in gastric cancer: functions and clinical applications.,Molecular Cancer,30;20(1):99.

Li Z, Li S, Ying X, Zhang L, Shan F, Jia Y, Ji J. The clinical value and usage of inflammatory and nutritional markers in survival prediction for gastric cancer patients with neoadjuvant chemotherapy and D2 lymphadenectomy.,Gastric Cancer,23(3):540-549.

ABCC2单核苷酸多态性预测胃癌新辅助化疗疗效的分子生物学基础, 课题负责人, 2019.1.1～2022.12.31, 国家自然科学基金 面上项目A001779

非进展期胃癌（T1／T2）保留胃功能手术的临床研究, 课题负责人, 2017.11.1～2022.3.31, 北京市科技计划课题D171100006517004

登峰人才计划：肿瘤学（李子禹）, 课题负责人, 2018.1.1～2021.12.31, 登峰人才计划DFL20181103